miR-122 continues to blaze the trail for microRNA therapeutics
Mol Ther
.
2010 Feb;18(2):240-2.
doi: 10.1038/mt.2009.313.
Authors
Dirk Haussecker
1
,
Mark A Kay
Affiliation
1
Department of Pediatrics and Genetics, Stanford University, Stanford, California, USA.
PMID:
20125164
PMCID:
PMC2839286
DOI:
10.1038/mt.2009.313
No abstract available
MeSH terms
Animals
Hepatitis C / therapy
Hepatitis C / virology
Humans
MicroRNAs / genetics
MicroRNAs / metabolism*
Pan troglodytes / virology
RNA Interference
Substances
MIRN122 microRNA, human
MicroRNAs